Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,243.00
Bid: 1,244.80
Ask: 1,245.80
Change: 18.80 (1.54%)
Spread: 1.00 (0.08%)
Open: 1,212.40
High: 1,247.00
Low: 1,210.80
Yest. Close: 1,224.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE 3-Drugmakers to join forces to make millions of Ebola vaccine doses

* J&J says has discussed collaboration with GlaxoSmithKline * J&J investing up to $200 mln to accelerate programme * Bavarian Nordic to receive cash injection from J&J (Recasts, adds comment on collaboration) By Ben Hirschler LONDON, Oct 22 (Reuters) - Leading drugmakers

22 Oct 14 11:27

GlaxoSmithKline holds dividend, eyes IPO of HIV unit

LONDON, Oct 22 (Reuters) - GlaxoSmithKline kept its dividend unchanged for the third quarter, breaking a run of steadily rising payouts, as U.S. pricing pressure on its top-selling lung drug Advair eroded sales and profit. Britain's biggest drugmaker said on Wednesday its 2015 dividend was

22 Oct 14 11:23

BUZZ-Glaxo tops FTSE on Q3 earnings beat

** GlaxoSmithKline rises 4.6 pct after reporting Q3 EPS of 27.9p, up 5 pct and above the 24p forecast by analysts. ** Biggest one-day rise for stock since April. ** Top riser on FTSE 100 at 1100 GMT. ** Q3 dividend maintained at 19p/shr FY 2014 div expected to be 80p, up 3 pct,

22 Oct 14 11:16

CORRECT: MARKET COMMENT: Earnings Drive Mixed UK Stocks

22 Oct 14 10:26

J&J, GSK ready to collaborate on Ebola vaccine work

LONDON, Oct 22 (Reuters) - Drugmakers will work together to accelerate development of an Ebola vaccine and Johnson & Johnson and GlaxSmithKline, both of which have experimental vaccine candidates, have already discussed collaboration. J&J, which aims to have at least 1 million doses of its

22 Oct 14 10:11

Wednesday broker round-up UPDATE

Amino Technologies: N+1 Singer moves target price from 93p to 107p upgrading to buy. Anglo American: Liberum Capital reduces target price from 1300p to 1200p retaining its sell recommendation. ARM Holdings: UBS moves target price from 970p to 980p upgrading from neutral to buy. Deutsche Bank cuts t

22 Oct 14 09:54

MARKET COMMENT: Earnings Drive Mixed UK Stocks, As BOE Stands Pat

22 Oct 14 09:49

UPDATE 2-J&J aims for 1 million Ebola vaccine doses in 2015

* Companies racing to develop first approved Ebola vaccine * J&J investing up to $200 mln to accelerate programme * Bavarian Nordic to receive cash injection from J&J * GSK and NewLink currently leading in vaccine development (Adds Bavarian Nordic share price jump, further det

22 Oct 14 08:47

UPDATE 1-J&J aims for 1 million Ebola vaccine doses in 2015

* Companies racing to develop first approved Ebola vaccine * J&J investing up to $200 mln to accelerate programme * Bavarian Nordic to receive cash injection from J&J * GSK and NewLink currently leading in vaccine development (Adds details on other vaccines, context) By

22 Oct 14 07:13

MARKET COMMENT: UK Stocks To Open Higher Ahead Of BoE Minutes

22 Oct 14 06:35

UK Earnings, Trading Statements Calendar - Week Ahead

22 Oct 14 05:14

REFILE-MSF aims to start drug trials in Ebola clinics next month

(Refiles to fix typo in first paragraph.) * MSF says priority will be treatments already available * Hopes trials can begin in November * MSF would not approve use of placebo in drug trials * Women and children should be included in tests By Daniel Flynn DAKAR,

21 Oct 14 17:48

MSF aims to start drug trials in Ebola clinics next month

* MSF says priority will be treatments already available * Hopes trials can begin in November * MSF would not approve use of placebo in drug trials * Women and children should be included in tests By Daniel Flynn DAKAR, Oct 21 (Reuters) - The medical charity Medecine

21 Oct 14 17:24

MARKET COMMENT: UK Stocks Gain As ECB Stimulus Hopes Boost Equities

21 Oct 14 16:18

RPT-Tens of thousands expected to get Ebola vaccines from January - WHO

(Repeats to additional clients.) * Clinical trials now under way to yield data on dosage * Health workers should get GSK, NewLink vaccines in Jan * Johnson & Johnson, Russia also have candidate vaccines By Stephanie Nebehay GENEVA, Oct 21 (Reuters) - Tens of thousand

21 Oct 14 15:40

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.